Owner: Director of Quality
Class: Operational Record (Class 3)
Status: Active — Pending sign-off
Last Updated: 2026-06-22
Cycle: 2026-06-19__release-v6.0

---

# Delivery Verification Report — 2026-06-19__release-v6.0

---

## §1 — Verification Status

**Status:** Verified_with_deviations

**Sprint goal:** Ship the P0 signal correctness fix and deliver the Trader's Morning Briefing and net-of-costs features to resolve the Product Value Alert, complete Screener data quality telemetry, and advance SI-05 effectiveness reviews as within-sprint gates clear.

**Cycle:** 2026-06-19__release-v6.0

**Backlog slice source:** `claude/cycles/2026-06-19__release-v6.0/stage4_backlog_slice.md` (original — no amendment)

**Verification run:** 2026-06-22T00:00:00Z

**Summary:**
- 11/11 in-scope stories traced to `done` with spec references
- All QA evidence logs: Pass (no Fail results)
- No formal DEV-* deviations; two P3 process deviations for ST-11 accepted under PO gate override
- Zero deferred execution blockers
- One test scenario gap requiring a backlog item (TSG-v60-01)
- System status report v6.0 section absent at verification invocation — added this run (STEP 6 correction; recurrence of v5.9 SSR pattern)

---

## §2 — Traceability Matrix

Authoritative backlog slice: `claude/cycles/2026-06-19__release-v6.0/stage4_backlog_slice.md`

| ST Item | Title | EPIC | Outcome | Spec Reference | Backlog Entry |
|---------|-------|------|---------|----------------|---------------|
| ST-01 | Align signal_service suggested_shares to risk-based sizing model | EPIC-01 | done | claude/strategy/strategy_rules.md#4.1; docs/specs/api_contracts/signal_endpoints.md | N/A |
| ST-02 | Trader's Morning Briefing dashboard | EPIC-02 | done | docs/specs/api_contracts/grace_period_alert_endpoint.md; docs/specs/api_contracts/position_endpoints.md; docs/specs/api_contracts/red_flag_journal.md; docs/specs/api_contracts/earnings_endpoints.md; docs/specs/api_contracts/analytics_endpoints.md | N/A |
| ST-03 | Net-of-costs performance tracking | EPIC-02 | done | docs/specs/api_contracts/trade_endpoints.md; docs/specs/data_model.md | N/A |
| ST-04 | Screener data quality telemetry | EPIC-03 | done | docs/specs/api_contracts/screener_api_contract.md | N/A |
| ST-05 | SI-05 deep link AC-04 staging confirmation | EPIC-03 | done | docs/specs/api_contracts/digest_endpoints.md | N/A |
| ST-06 | RFJ design review pre-brief | EPIC-04 | done | claude/cycles/2026-06-19__release-v6.0/stage4_backlog_slice.md#ST-06; docs/design/2026-06-19__release-v6.0/rfj-design-review/brief.md | N/A |
| ST-07 | Red Flag Journal visual design review | EPIC-04 | done | claude/cycles/2026-06-19__release-v6.0/stage4_backlog_slice.md#ST-07; docs/design/2026-06-19__release-v6.0/rfj-design-review/review.md | N/A |
| ST-08 | SI-05 digest weekly cadence review | EPIC-04 | done | claude/cycles/2026-06-19__release-v6.0/stage4_backlog_slice.md#ST-08; docs/product/decisions/si05-digest-cadence-review--2026-06-22.md | N/A |
| ST-09 | SI-05 digest actionability metric definition | EPIC-04 | done | claude/cycles/2026-06-19__release-v6.0/stage4_backlog_slice.md#ST-09; docs/product/decisions/si05-actionability-metrics-definition.md | N/A |
| ST-10 | SI-05 Phase 2 activation decision scope | EPIC-04 | done | claude/cycles/2026-06-19__release-v6.0/stage4_backlog_slice.md#ST-10; docs/product/decisions/si05-phase2-activation-decision--2026-06-22.md | N/A |
| ST-11 | SI-05 service production p99 latency baseline review | EPIC-04 | done | claude/cycles/2026-06-19__release-v6.0/stage4_backlog_slice.md#ST-11; docs/testing/staging_latency_review_ST-11.md | N/A |

**Traceability gaps:** 0 | **Items returned:** 0 | **Backlog entries added this run:** 0

---

## §3 — QA Evidence Summary

| EPIC | Items | Pass | Fail | Sign-off | Notes |
|------|-------|------|------|----------|-------|
| EPIC-01 | 1 | 1 | 0 | ✓ Sprint Execution Engine (autonomous class) 2026-06-19 | BLG-GOV-19 autonomous class: all 4 criteria met; AC-01 additionally cleared by Strategy Rules & System Intent Owner (agent-mediated §5.3) |
| EPIC-02 | 2 | 2 | 0 | ✓ Director of Quality (agent-mediated, BLG-GOV-19) 2026-06-19 | ST-02: 11 Playwright scenarios; ST-03: 5 Playwright scenarios; AC-09 and all frontend-visible ACs covered |
| EPIC-03 | 2 | 2 | 0 | ✓ Director of Quality (agent-mediated, BLG-GOV-19) 2026-06-19 + I&O Owner addendum 2026-06-22 | ST-04: 5 Playwright scenarios; ST-05: staging confirmation by I&O Owner 2026-06-22 |
| EPIC-04 | 6 | 6 | 0 | ✓ Director of Quality 2026-06-22 | Documentation-only EPIC; all ACs verified via delegated role sign-offs (HoUX&D, PO, Metrics Definitions & Analytics Owner, I&O Owner). PO acceptance 2026-06-22. |

**QA sign-off authority check (STEP -1.3):**
- EPIC-01: "Sprint Execution Engine (autonomous class)" — BLG-GOV-19 autonomous class criteria verified (all 4 met). Tier 1/2 compliant.
- EPIC-02: "Director of Quality (agent-mediated, BLG-GOV-19)" — Director of Quality named in signer; Tier 1/2 compliant.
- EPIC-03: "Director of Quality (agent-mediated, BLG-GOV-19)" + I&O Owner staging addendum — Director of Quality named for ST-04; I&O Owner appropriate authority for staging-only ACs (ST-05). Compliant.
- EPIC-04: "Director of Quality" — explicit DoQ sign-off with date; fully compliant.

---

## §4 — Deviation Register

**Formal DEV-* deviations (from sprint_close.md "Deviations filed this sprint"):** None.

`sprint_close.md` documents: "No spec deviations (implementation diverging from what the spec requires) were filed via /dev-file."

**P3 process deviations (documented in qa_evidence_EPIC-04.md and execution_state.json; accepted under PO gate override 2026-06-20):**

| Deviation Ref | ST Item | Priority | Description | Disposition | Backlog Item |
|---------------|---------|----------|-------------|-------------|--------------|
| ST-11-DEV-1 | ST-11 | P3 | 16-day measurement window used for p99 latency baseline review vs ≥4-week requirement in spec (BLG-OPS-59 AC spec) | Recorded — PO gate override 2026-06-20; I&O Owner sign-off 2026-06-22; 7 successful dispatches confirm functional adequacy | BLG-OPS-54 (scope revised to Render internal log approach) |
| ST-11-DEV-2 | ST-11 | P3 | AC-02 N/A — no BLG-OPS-54 prior baseline exists (POST /digest/si05/send excluded from §19 standard run; Telegram API blocks external measurement) | Recorded — PO gate override 2026-06-20; PASS WITH DEVIATION accepted; BLG-OPS-54 scope updated to correct measurement method | BLG-OPS-54 |

**Hard blocks:** None.

**Acceptance records:** P3 deviations require no PO/DoQ acceptance record for `Verified_with_deviations` status. PO gate override 2026-06-20 covers both P3 items. Both items reference BLG-OPS-54 which is confirmed in `claude/backlog/backlog.md`.

**Canonical spec Known Deviations sync (LL-v2.3-CL-03):** ST-11's spec reference is `stage4_backlog_slice.md#ST-11` — this is a planning document, not a canonical spec contract file. No canonical spec Known Deviations section is applicable for these measurement-constraint P3 items. No action required.

---

## §5 — Outstanding Items and Deferred Execution Blockers

### (a) Outstanding Items Carried to Backlog

**Delegated items at sprint close:** All 5 delegation records (DEL-20260620-01 through DEL-20260620-05) reached terminal state `Unblocked` during the sprint. No delegations outstanding at close.

**Open escalations at sprint close:** None. All execution escalations (ESC-2026-06-19-01 through ESC-2026-06-19-04) resolved during the sprint via PO gate overrides (2026-06-20).

| Item | Type | Outcome | Backlog ref |
|------|------|---------|-------------|
| BLG-FE-66 — RFJ date-range filter (date-to field) | P3 backlog item from ST-07 design review | Filed at sprint execution (HoUX&D sign-off 2026-06-22) | BLG-FE-66 confirmed in backlog.md |
| BLG-FE-67 — RFJ event type colour palette refinement | P3 backlog item from ST-07 design review | Filed at sprint execution (HoUX&D sign-off 2026-06-22) | BLG-FE-67 confirmed in backlog.md |
| BLG-QA-60 — Register new Playwright specs in playwright.yml | Playwright CI gap from EPIC-02/03 | Filed at sprint execution 2026-06-22 | BLG-QA-60 confirmed in backlog.md |
| BLG-OPS-54 — POST /digest/si05/send p99 baseline | BLG-OPS-54 scope revised to Render internal log approach (ST-11) | Scope updated at sprint execution | BLG-OPS-54 confirmed in backlog.md |

All outstanding items are confirmed in `claude/backlog/backlog.md`. No additions required.

### (b) Deferred Execution Blockers

`state.json.deferred_execution_blockers = []` — no deferred execution blockers at release planning. Nothing to disposition.

### (c) Stale Parked Items

Zero items in the authoritative backlog slice have `status = parked`. All 11 items were active/conditional and delivered. **Step 4.3 skipped** (per short-circuit rule: zero parked items).

---

## §6 — Test Coverage Assessment

### EPIC-01 — Signal Correctness Fast-Track

**Test scenarios in execution_state.json:** `["docs/testing/signals_scenarios.md"]`

**QA evidence scenarios run:** `tests/test_signal_sizing.py` (new — covers AC-02/03/04/05); `tests/test_api_contracts.py` (existing — mocked, unaffected)

**Gap:** `docs/testing/signals_scenarios.md` is listed as an available test scenario but was not referenced as run in qa_evidence_EPIC-01.md. The QA evidence instead used the newly created `tests/test_signal_sizing.py` which covers all story-specific ACs. However, `signals_scenarios.md` documents broader signal domain scenarios that may include cases affected by the signal sizing model change (e.g., end-to-end signal generation → suggested_shares scenarios). These broader scenarios were not explicitly run or confirmed unaffected.

**Coverage gap feedback for QA & Testing Owner:**

```
## Test Coverage Gap — EPIC-01: Signal Correctness Fast-Track

Gap type: Scenarios existed but not run
Spec sections covered by this EPIC:
  - claude/strategy/strategy_rules.md#4.1 (risk-based sizing formula)
  - docs/specs/api_contracts/signal_endpoints.md (suggested_shares field)
Acceptance criteria not covered by existing scenarios in signals_scenarios.md:
  - Any signal generation → sizing model integration scenarios in signals_scenarios.md
    should be reviewed to confirm they remain valid post ST-01 (cash-allocation
    model removed; risk-based formula now canonical for suggested_shares)
Recommended new scenarios / review actions:
  - Review: docs/testing/signals_scenarios.md — check each scenario for
    suggested_shares assertions that assumed the old cash-allocation model
  - Update any scenario expecting suggested_shares based on cash/n_signals
    to instead assert the risk-based formula output
  - Target: confirm or update signals_scenarios.md before next sprint touching
    signal generation or the sizing service
Action required:
  QA & Testing Owner to review docs/testing/signals_scenarios.md against ST-01
  changes, update any stale scenario assertions, and confirm coverage status.
  Target: before next sprint touching signal generation.
```

Backlog item added: **BLG-QA-61** — `[TEST-GAP-EPIC-01] signals_scenarios.md not run in v6.0 QA — QA & Testing Owner to review signal scenarios against ST-01 sizing model changes per verification_report.md §6. Target: pre-next sprint on signal generation domain.` (added to backlog.md this run)

---

### EPIC-02 — User Intelligence Features

**Test scenarios in execution_state.json:** `["docs/testing/staging_visual_test_script_EPIC-02.md"]`

**QA evidence scenarios run:** `tests/e2e/morning-briefing.spec.js` (11 tests); `tests/e2e/net-r-trade-history.spec.js` (5 tests); `tests/e2e/system-status.spec.js` SC-SS-01b

**Assessment:** `docs/testing/staging_visual_test_script_EPIC-02.md` is a staging visual review script for human eyes-on verification post-deploy. Playwright tests cover all 9 ACs for ST-02 (including AC-09 explicitly requiring Playwright coverage) and all 5 ACs for ST-03. The staging visual script is supplementary to automated coverage — it is appropriate for post-deploy staging review, not CI QA sign-off. No genuine coverage gap for CI-verifiable ACs.

**Disposition:** `deferred` — staging visual test script to be run post-deploy to production as part of release verification. Playwright coverage satisfies all CI-verifiable AC requirements. No backlog item required for the script itself.

---

### EPIC-03 — Screener Quality & Ops Closure

**Test scenarios in execution_state.json:** `["tests/e2e/screener-quality.spec.js", "docs/testing/screener_accuracy_protocol.md", "docs/testing/staging_visual_test_script_EPIC-03.md"]`

**QA evidence scenarios run:** `tests/e2e/screener-quality.spec.js` (5 tests — all three run_quality states, expandable ticker list, stale advisory)

**Assessment:**
- `screener-quality.spec.js`: referenced and run ✓ — covers all 7 ACs for ST-04
- `docs/testing/screener_accuracy_protocol.md`: not referenced in QA evidence. This is a broader screener accuracy protocol for manual verification of data quality (created in a prior sprint). It was not required for ST-04 ACs which are entirely about the quality telemetry display (not the underlying data accuracy). Appropriate for staging/production validation, not sprint QA sign-off.
- `docs/testing/staging_visual_test_script_EPIC-03.md`: not referenced in QA evidence. Same pattern as EPIC-02 — supplementary staging visual review.

**Disposition:** Both `screener_accuracy_protocol.md` and `staging_visual_test_script_EPIC-03.md` are `deferred` to post-deploy staging review. All CI-verifiable ACs satisfied by screener-quality.spec.js Playwright tests. No backlog item required.

---

### EPIC-04 — SI-05 Effectiveness Reviews & RFJ Design

**Test scenarios in execution_state.json:** `[]` (empty)

**Assessment:** EPIC-04 is a documentation-only EPIC — all 6 stories deliver design artefacts, product decisions, metrics definitions, and staging evidence. No frontend-visible changes. No code changes. No automated test scenarios are applicable.

**Short-circuit applied:** `test_scenarios = []` AND no frontend-visible AC (documentation/decision-only class). Disposition: `not_applicable`.

---

### Test Scenario Gaps — Structured Register

| gap_id | EPIC | Description | Qualifying reason | Disposition |
|--------|------|-------------|-------------------|-------------|
| TSG-v60-01 | EPIC-01 | docs/testing/signals_scenarios.md listed in test_scenarios but not referenced as run — broader signal domain scenarios may contain stale assertions after cash-allocation model removal | Core signal domain regression risk; signals_scenarios.md covers end-to-end signal generation scenarios not all covered by new test_signal_sizing.py | backlog_item_created — BLG-QA-61 |
| TSG-v60-02 | EPIC-02 | docs/testing/staging_visual_test_script_EPIC-02.md listed but not run in sprint QA | Staging visual script is supplementary to Playwright coverage; all CI-verifiable ACs satisfied by Playwright tests | deferred — post-deploy staging review; Playwright satisfies all sprint QA requirements |
| TSG-v60-03 | EPIC-03 | docs/testing/screener_accuracy_protocol.md and docs/testing/staging_visual_test_script_EPIC-03.md listed but not run in sprint QA | Both are staging/production verification scripts; screener-quality.spec.js covers all 7 AC-07 test requirements | deferred — post-deploy staging review |
| TSG-v60-04 | EPIC-04 | test_scenarios = [] | Documentation-only EPIC; no frontend-visible ACs; no automated test scenarios applicable | not_applicable — EPIC-04 is documentation/decision class only |

---

## §7 — System Status Report Confirmation

**At verification invocation:** `docs/System_status_report.md` did not contain a `## Sprint: 2026-06-19__release-v6.0` section. The most recent section was `## Sprint: 2026-06-17__release-v5.9`. This is a recurrence of the SSR-absent-at-verification pattern from v5.9 Phase 4 (LL-v5.9-P4-01 patch was applied to execution_prompt.md v3.44→v3.45 on 2026-06-18 but did not prevent the recurrence in v6.0; root cause: STEP 5.3A section write was skipped during sprint close, only STEP 5.1.B integrity advisory was followed).

**Correction applied this run:** v6.0 section added to `docs/System_status_report.md` during STEP 6. Version updated to 4.1.

**v6.0 section content confirms:**
- All 4 merged EPICs appear in "Capabilities now live" with correct spec references
- No items returned to backlog (all 11 delivered)
- ST-11 P3 deviations noted under SI-05 p99 review row

---

## §9 — Sign-off Block

## Director of Quality Sign-off

- [x] Traceability complete (or gaps documented with rationale)
- [x] QA evidence reviewed and accepted
- [x] Deviation register reviewed; all P0/P1/P2 dispositions confirmed
- [x] Test coverage gaps actioned (backlog items created)
- [x] System status report confirmed accurate
- [x] Deferred execution blockers dispositioned

Signed off by: Director of Quality
Date: 2026-06-22
Comments: All 11 stories verified. QA evidence complete across 4 EPICs with valid sign-off chains. No P0/P1/P2 deviations. Two P3 measurement-constraint deviations for ST-11 accepted under PO gate override — BLG-OPS-54 backlog confirmed. TSG-v60-01 (BLG-QA-61) filed for signals_scenarios.md review. SSR v6.0 section added this run. System status report reconciliation complete. Verification evidence is consistent and traceable.

## Product Owner Acceptance

- [x] Outstanding items confirmed in backlog
- [x] P1/P2 deviation acceptances confirmed (if any)
- [x] Deferred execution blocker outcomes acknowledged
- [x] Next cycle cleared to open

Accepted by: Product Owner
Date: 2026-06-22
Comments: Sprint goal 100% delivered. ST-11 P3 deviations were accepted under my gate override authority (2026-06-20) — BLG-OPS-54 scope revised accordingly. All EPIC-04 conditional gates cleared. BLG-FE-66, BLG-FE-67, BLG-QA-60, BLG-QA-61 confirmed in backlog. No deferred execution blockers. Next cycle may open.
